Untapped potential of wild medicinal flora: HPLC-based characterization, enzyme inhibition and antioxidant properties of Macrochloa tenacissima (L.) kunth and Sinapis arvensis extracts

2025

Closed access Metadata (CSL-JSON)
DOI 10.1080/14786419.2025.2577770
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This study investigated the chemical composition and biological activities of Macrochloa tenacissima and Sinapis arvensis using HPLC-DAD and in vitro assays. HPLC analysis revealed that M. tenacissima flowers contained apigenin (1.15 mg/g), luteolin (0.74 mg/g) and epicatechin (0.52 mg/g), along with traces of theobromine, theophylline and coumarins, whereas S. arvensis was rich in caffeic (0.80 mg/g) and ferulic acids (0.09 mg/g). Antioxidant assays demonstrated that methanol extracts of M. tenacissima exhibited strong DPPH (148.45 ± 5.88 µg/mL) and ABTS (50.44 ± 5.94 µg/mL) scavenging, while S. arvensis showed the highest cupric reducing power (138.61 ± 3.17 µg/mL). Enzyme inhibition assays indicated that M. tenacissima exerted the strongest butyrylcholinesterase (446.92 ±­23.96 µg/mL) and tyrosinase inhibition (693.57 µg/mL). These findings, representing the first report on M. tenacissima bioactivities, highlight the pharmacological potential of both species as valuable sources of natural antioxidants and enzyme inhibitors.